EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Screening for brain‐related comorbidities in Duchenne muscular dystrophy: Construction, reliability, and validity of the BIND screener

Ruben Miranda, Pien M M Weerkamp, Anna Kolesnik, Chloe Geagan, Daniela Chieffo, Mariana Suárez-Bagnasco, David Skuse, Elizabeth Vroom, Erik H Niks, John Vissing, Isabelle Desguerre, Volker Straub und 4 weitere

Developmental Medicine & Child Neurology · 2026-08 · 68 (8) · 1080-1096

DOI: 10.1111/dmcn.70145 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Developmental Medicine & Child Neurology, online erschienen am 14.01.2026. Verfasst von Ruben Miranda und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychobiology and Methodology in Behavioral Sciences, Universidad Complutense de Madrid, Madrid, Spain. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Brain Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Parent Project Muscular Dystrophy, Duchenne Parent Project, European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To develop a brief, reliable, and valid screening tool and to provide normative data for the identification of individuals with Duchenne muscular dystrophy (DMD) at risk of brain‐related comorbidities.

Method

An 18‐item proxy/self‐report screening tool covering nine comorbidity areas was developed on the basis of existing literature and expert consensus, and translated into 11 languages. In this cross‐sectional observational study, data from 835 individuals with DMD (aged 5–42 years) were used to assess reliability, construct validity, and diagnostic accuracy. A subsample of 90 participants completed cognitive and behavioural assessments for concurrent validity analyses.

Results

The Brain Involvement iN Dystrophinopathies (BIND) screener showed excellent internal consistency ( α = 0.89) and a factor structure aligned with theoretical domains. Age‐related patterns were observed across domains. The total score (Duchenne Brain Comorbidity Score) correlated with clinical and cognitive markers in the validation subsample. Receiver operating characteristic analysis in the full sample yielded an area under the curve of 0.78, with a cut‐off score of 20/72 providing optimal sensitivity (71.6%) and specificity (72.5%) for identifying parent‐ or self‐reported neurodevelopmental conditions previously diagnosed by professionals.

Interpretation

The BIND screener is a brief, psychometrically robust tool that facilitates early identification of brain‐related comorbidities in DMD and may be applied in both clinical practice and research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, DuchenneBrain DiseasesHumansMaleCross-Sectional StudiesChildReproducibility of ResultsAdolescentChild, PreschoolYoung AdultAdultComorbidityFemalePsychometrics

Autor:innen und Institutionen

  • Department of Psychobiology and Methodology in Behavioral Sciences, Universidad Complutense de Madrid, Madrid, Spain.
  • Kempenhaeghe Centre for Neurological Learning Disabilities, Heeze, Netherlands.
  • Maastricht University, School for Mental Health and Neuroscience, Maastricht, Netherlands.
  • Leiden University Medical Center, Department of Neurology, Leiden, Netherlands.
  • Dubowitz Neuromuscular Centre, Great Ormond Street Institute of Child Health, UCL and NIHR Biomedical Research Centre, London, UK.
  • John Walton Muscular Dystrophy Research Centre, NIHR Newcastle Biomedical Research Centre, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Förderung

  • Parent Project Muscular Dystrophy
  • Duchenne Parent Project
  • European Commission

Zitieren

APA

Miranda, R., Weerkamp, P. M. M., Kolesnik, A., Geagan, C., Chieffo, D., Suárez-Bagnasco, M., Skuse, D., Vroom, E., Niks, E. H., Vissing, J., Desguerre, I., Straub, V., Muntoni, F., Mercuri, E., Hendriksen, J. G. M., & BIND Consortium (2026). Screening for brain‐related comorbidities in Duchenne muscular dystrophy: Construction, reliability, and validity of the BIND screener. Developmental Medicine & Child Neurology, 68(8), 1080-1096. https://doi.org/10.1111/dmcn.70145

Vancouver

Miranda R, Weerkamp PMM, Kolesnik A, Geagan C, Chieffo D, Suárez-Bagnasco M, et al. Screening for brain‐related comorbidities in Duchenne muscular dystrophy: Construction, reliability, and validity of the BIND screener. Developmental Medicine & Child Neurology. 2026;68(8):1080-1096. doi:10.1111/dmcn.70145

BibTeX
@article{Miranda2026,
  author = {Miranda, Ruben and Weerkamp, Pien M M and Kolesnik, Anna and Geagan, Chloe and Chieffo, Daniela and Suárez-Bagnasco, Mariana and Skuse, David and Vroom, Elizabeth and Niks, Erik H and Vissing, John and Desguerre, Isabelle and Straub, Volker and Muntoni, Francesco and Mercuri, Eugenio and Hendriksen, Jos G M and BIND Consortium, BIND Consortium},
  title = {Screening for brain‐related comorbidities in Duchenne muscular dystrophy: Construction, reliability, and validity of the BIND screener},
  journal = {Developmental Medicine & Child Neurology},
  year = {2026},
  volume = {68},
  number = {8},
  pages = {1080--1096},
  doi = {10.1111/dmcn.70145}
}
Kostenlos starten →